UBS Group’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
Other funds holding SBRA
CIM
UBS Group's SBRA Position: Q2 2026 in Review
UBS Group reduced its Sabra Healthcare REIT (SBRA) stake by 63% in Q2 2026, selling an estimated $20.3M and leaving 611,431 shares worth $11.9M. The position accounts for ﹤0.01% of the portfolio, ranked #3259.
UBS Group first reported a position in SBRA in Q4 2014 and has held it in 47 quarters since. The position peaked at $31.5M in Q1 2026. 465 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.
- UBS Group held 611,431 shares of Sabra Healthcare REIT worth $11.9M as of Q2 2026.
- UBS Group sold 1,025,242 Sabra Healthcare REIT shares in Q2 2026, an estimated $20.3M.
- Sabra Healthcare REIT made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3259 holding.
- UBS Group first reported a position in Sabra Healthcare REIT in Q4 2014 and has held it in 47 quarters since.
- UBS Group's Sabra Healthcare REIT position peaked at $31.5M in Q1 2026.
- 465 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.